A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 25727
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SLE
Long Form : systemic lupus erythematosus
No. Year Title Co-occurring Abbreviation
2021 Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment. ALG, IVIS, MSCs, PDL, PEO
2021 Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models. DAH, MYXV
2020 'The feeling of not being entitled to something': fertility, pregnancy, and sexuality among women with systemic lupus erythematosus in South Africa. ---
2020 24-hour Activity and Sleep Profiles for Adults Living with Arthritis: Habits Matter. OA, RA
2020 A case of complete atrioventricular block in secondary hemophagocytic syndrome/hemophagocytic lymphohistiocytosis recovered by plasma exchange and cytokine absorbing therapy with AN69ST continuous hemodiafiltration. CAVB, PE
2020 A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature. HQ
2020 A Case of Kikuchi-Fujimoto Disease in a 7-Year-Old African American Patient: A Case Report and Review of Literature. KFD
2020 A case of severe choroidal detachment in both eyes due to systemic lupus erythematosus. BCVA, CDs, IOP, SRDs
2020 A case of systemic lupus erythematosus associated auto-splenectomy presenting as invasive pneumococcal sepsis. ---
10  2020 A case of systemic lupus erythematosus with rectal necrosis. ---
11  2020 A Case with Purine Nucleoside Phosphorylase Deficiency Suffering from Late-Onset Systemic Lupus Erythematosus and Lymphoma. HSCT, PNP
12  2020 A case-control study of oral diseases and quality of life in individuals with rheumatoid arthritis and systemic lupus erythematosus. CG, FT, GI, HRQoL, M-T, OHIP-14, OHRQoL, PI, QOL, RA, SWSFR, UWSFR, XI
13  2020 A cat's scratch or a wolf's bite? ---
14  2020 A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus. ---
15  2020 A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis. EULAR/ACR, RA
16  2020 A Comparative Study on the Incidence, Aggravation, and Remission of Lupus Nephritis Based on iTRAQ Technology. ELISA, iTRAQ, LN, LPS, NS
17  2020 A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum. ---
18  2020 A Flare-up of Systemic Lupus Erythematosus with Unusual Enteric Predominance. GI, RUQ, SLEDAI
19  2020 A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus. CsA
20  2020 A Missense Variant Affecting the C-Terminal Tail of UNC93B1 in Dogs with Exfoliative Cutaneous Lupus Erythematosus (ECLE). CLE, ECLE, GWAS, SDCBP, TLRs
21  2020 A new target for the treatment of inflammatory bowel disease: Interleukin-37. DCs, IBD, IL, MS, RA
22  2020 A novel immunochromatographic strips assay for rapid and simple detection of systemic lupus erythematosus. ANA, AOL, dot-ELISA, ICS, IgG, SpG3
23  2020 A novel long-acting azathioprine polyhydroxyalkanoate nanoparticle enhances treatment efficacy for systemic lupus erythematosus with reduced side effects. AZA, PHA, PHBVHHx, PLA
24  2020 A Novel Network Pharmacology Strategy to Decode Mechanism of Lang Chuang Wan in Treating Systemic Lupus Erythematosus. CI, KGEC, LCW, PPI, TCM
25  2020 A Novel Small-Molecule Inhibitor of Endosomal TLRs Reduces Inflammation and Alleviates Autoimmune Disease Symptoms in Murine Models. NF-kappaB, TLRs, TNF-alpha
26  2020 A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus. HF
27  2020 A Quality Improvement Intervention to Reduce 30-Day Hospital Readmission Rates among Patients with Systemic Lupus Erythematosus. ---
28  2020 A Rare Case of Hemoglobin E/Beta-Thalassemia and Systemic Lupus Erythematosus. ---
29  2020 A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. anti-RibP, LN, NPSLE
30  2020 A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. NL
31  2020 A review of non-immune mediated kidney disease in systemic lupus erythematosus: A hypothetical model of putative risk factors. LN
32  2020 A Sensitive and Optimized HPLC-FLD Method for the Simultaneous Quantification of Hydroxychloroquine and Its Two Metabolites in Blood of Systemic Lupus Erythematosus Patients. HCQ
33  2020 A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus. HRM-qPCR, IFI44L
34  2020 A Spatiotemporal Analysis of Organ-Specific Lupus Flares in Relation to Atmospheric Variables and Fine Particulate Matter Pollution. VAS
35  2020 A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies. Ab, autoAb, HCMV, SjS, SSc
36  2020 A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine. G6PD, RA
37  2020 A successful case of lupus myelitis treated with intravenous pulse methylprednisolone and pulse cyclophosphamide therapy. ---
38  2020 A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy. aHUS, LN, PNH, TMA
39  2020 A Tale of Two Valves: Bioprosthetic Aortic Valve Obstruction in Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome. APLAS
40  2020 A Teenager With Rash and Fever: Juvenile Systemic Lupus Erythematosus or Kawasaki Disease? KD
41  2020 A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus. TSDR, tTreg
42  2020 Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients. BCMA
43  2020 Abnormal membrane-bound and soluble programmed death ligand 2 (PD-L2) expression in systemic lupus erythematosus is associated with disease activity. PD-1, PD-L, PD-L2, sPD-L2
44  2020 Abnormal topological organization in systemic lupus erythematosus: a resting-state functional magnetic resonance imaging analysis. FC
45  2020 Abrogated AID Function Prolongs Survival and Diminishes Renal Pathology in the BXSB Mouse Model of Systemic Lupus Erythematosus. AID
46  2020 Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus. CSF, NMDARs, NPSLE
47  2020 Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients. IRP, MMSE, MoCA
48  2020 Access and cost-related non-adherence to prescription medications among lupus cases and controls: the Michigan Lupus Epidemiology & Surveillance (MILES) Program. MILES
49  2020 Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort. AVEs, HR
50  2020 Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. HDs, IFN-gamma, IL-12, NK, SLEDAI
51  2020 Active human herpesvirus infections in adults with systemic lupus erythematosus and correlation with the SLEDAI score. HHVs
52  2020 Activity Disease in SLE Patients Affected IFN-gamma in the IGRA Results. IFN, TB
53  2020 Acute Generalized Cutaneous Lupus Erythematosus Repeatedly Mistaken for Cellulitis. ACLE, CLE
54  2020 Acute liver failure as the first feature of systemic lupus erythematosus. GI
55  2020 Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review. MAS
56  2020 Acute severe sensory ganglionopathy in systemic lupus erythematous. PNS
57  2020 Acute Syphilitic Posterior Placoid Chorioretinitis Misdiagnosed as Systemic Lupus Erythematosus Associated Uveitis. ASPPC
58  2020 Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus among Patients with Systemic Lupus Erythematosus: A Population-Based Study. CI, PDC, T2DM
59  2020 Adherence to hydroxychloroquine in patients with systemic lupus: Contrasting results and weak correlation between assessment tools. HCP, HCQ, MASRI, VAS
60  2020 Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection. AOSD, HLH, IVIG, MAS, PE
61  2020 Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study. ---
62  2020 Advances in applying of multi-omics approaches in the research of systemic lupus erythematosus. ---
63  2020 Advances In Drug Therapy For Systemic Lupus Erythematosus. ---
64  2020 Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway. ---
65  2020 Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus. NPSLE
66  2020 Adverse pregnancy outcome and connective tissue disease: why is there a link? APO, APS, CTD
67  2020 Adverse Pregnancy Outcomes after Multi-Professional Follow-Up of Women with Systemic Lupus Erythematosus: An Observational Study from a Single Centre in Sweden. aPL, APO, APS
68  2020 Adverse pregnancy outcomes among multi-ethnic systemic lupus erythematosus patients in Malaysia. APOs, GEE, IUGR
69  2020 Adverse pregnancy outcomes and subsequent development of connective tissue disease in the UK: an epidemiological study. aPL, APS, CPRD, CTDs, RR
70  2020 Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort. FACIT-FT, HRQoL, SLEDAI-2K, SLICC
71  2020 All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database. NIS
72  2020 Allergic rhinitis and risk of systemic lupus erythematosus: A systematic review and meta-analysis. AR, CI, OR, RR
73  2020 alpha2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responses. alpha2-AP, IFN-gamma, JNK, LN
74  2020 Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. HC
75  2020 Alterations in peripheral blood B cells in systemic lupus erythematosus patients with renal insufficiency. LN, RI
76  2020 Altered frequency of peripheral B-cell subsets and their correlation with disease activity in patients with systemic lupus erythematosus: A comprehensive analysis. CLP, CSM-B, HSC, MB, N-B, NSM-B
77  2020 Altered microvascular density in patients with systemic lupus erythematosus treated with hydroxychloroquine-an optical coherence tomography angiography study. CRT, FAZ, HCQ, OCTA, SCP
78  2020 Altered redox regulation by Nrf2-Keap1 system in dendritic cells of systemic lupus erythematosus patients. DCs, Keap1, pDCs, ROS
79  2020 American Indians Have a Higher Risk of Sjogren's Syndrome and More Disease Activity Than European Americans and African Americans. AA, AI, EA, ESR, OR, SS
80  2020 Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study. AEs, EOT
81  2020 An Allele-Specific Functional SNP Associated with Two Systemic Autoimmune Diseases Modulates IRF5 Expression by Long-Range Chromatin Loop Formation. SSc
82  2020 An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea. AIRDs, AS, RA
83  2020 An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus. BNs, CPN, PBMC
84  2020 An Overlapping Case of IgG4-related Disease and Klinefelter Syndrome with Lupus-like Serological and Neurological Features: A Case Report and Literature Review. IgG4-RD, KS
85  2020 An uncommon overlap of two common rheumatological disorders. ---
86  2020 An Unusual and Rare Case of a Seronegative Male Patient With Lupus Nephritis. ANA, EULAR/ACR, MMF
87  2020 An unusual neurological presentation: systemic lupus erythematosus mimicking central nervous system infection. CNS
88  2020 An update on genetic susceptibility in lupus nephritis. GWAS, LN
89  2020 An update on genetic susceptibility in lupus nephritis. GWAS, LN
90  2020 An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice. CLE
91  2020 An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus. CI, HR
92  2020 Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases. ANAs, HC, IIFA, MCTD, PPV, pSS, RA, SARD, SSc
93  2020 Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice. GC-MS, NPSLE, PCA
94  2020 Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China. CI, LN
95  2020 Analysis of Foveal Microvascular Abnormalities in Patients with Systemic Lupus Erythematosus Using Optical Coherence Tomography Angiography. DCP, FAZ, OCTA
96  2020 Analysis of gene expression from systemic lupus erythematosus synovium reveals myeloid cell-driven pathogenesis of lupus arthritis. DEGs, GCs, GSVA, LA, OA, RA, WGCNA
97  2020 Analysis of IL-22 and Th22 Cells by Flow Cytometry in Systemic Lupus Erythematosus. IL, Th
98  2020 Analysis of the receptor BCMA as a biomarker in systemic lupus erythematosus patients. HCs, sBCMA
99  2020 Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries. AA, EA
100  2020 Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus. MDSCs